Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNA

The oncogenic Epstein-Barr virus (EBV) evades the immune system but has an Achilles heel: its genome maintenance protein EBNA1, which is essential for viral genome maintenance but highly antigenic. EBV has seemingly evolved a system in which the mRNA sequence encoding the glycine-alanine repeats (GAr) of the EBNA1 protein limits its expression to the minimal level necessary for function while minimizing immune recognition. Here, we identify nucleolin (NCL) as a host factor required for this process via a direct interaction with G-quadruplexes formed in GAr-encoding mRNA sequence. Overexpression of NCL enhances GAr-based inhibition of EBNA1 protein expression, whereas its downregulation relieves the suppression of both expression and antigen presentation. Moreover, the G-quadruplex ligand PhenDC3 prevents NCL binding to EBNA1 mRNA and reverses GAr-mediated repression of EBNA1 expression and antigen presentation. Hence the NCL-EBNA1 mRNA interaction is a relevant therapeutic target to trigger an immune response against EBV-carrying cancers.

[1]  N. Blake.  Immune evasion by gammaherpesvirus genome maintenance proteins. , 2010, The Journal of general virology.

[2]  P. Murat,et al.  Effects of messenger RNA structure and other translational control mechanisms on major histocompatibility complex‐I mediated antigen presentation , 2014, Wiley interdisciplinary reviews. RNA.

[3]  R. Fåhraeus,et al.  mRNA Translation Regulation by the Gly-Ala Repeat of Epstein-Barr Virus Nuclear Antigen 1 , 2008, Journal of Virology.

[4]  Shankar Balasubramanian,et al.  Existence and consequences of G-quadruplex structures in DNA. , 2014, Current opinion in genetics & development.

[5]  S. Balasubramanian,et al.  SURVEY AND SUMMARY 5 0 -UTR RNA G-quadruplexes: translation regulation and targeting , 2012 .

[6]  M. Gorospe,et al.  RNA-binding protein nucleolin in disease , 2012, RNA biology.

[7]  Zoltán Konthur,et al.  Identification and characterization of RNA guanine-quadruplex binding proteins , 2014, Nucleic acids research.

[8]  R. Fåhraeus,et al.  Epstein–Barr virus‐encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV‐carrying cancers , 2015, The Journal of pathology.

[9]  N. Maizels,et al.  The G4 Genome , 2013, PLoS genetics.

[10]  J. Mergny,et al.  Telomerase downregulation induced by the G-quadruplex ligand 12459 in A549 cells is mediated by hTERT RNA alternative splicing. , 2004, Nucleic acids research.

[11]  A. Nicolas,et al.  Genetic instability triggered by G-quadruplex interacting Phen-DC compounds in Saccharomyces cerevisiae , 2010, Nucleic acids research.

[12]  S. Cheung,et al.  Characterization of a new EBV-associated nasopharyngeal carcinoma cell line. , 1998, Cancer genetics and cytogenetics.

[13]  Stefan Imreh,et al.  Inhibition of antigen processing by the internal repeat region of the Epstein–Barr virus nuclear antigen-1 , 1995, Nature.

[14]  H. Lipps,et al.  G-quadruplexes and their regulatory roles in biology , 2015, Nucleic acids research.

[15]  M. Peter,et al.  Isolation and characterization of HRT1 using a genetic screen for mutants unable to degrade Gic2p in saccharomyces cerevisiae. , 2000, Genetics.

[16]  J. Mandel,et al.  The G-quartet containing FMRP binding site in FMR1 mRNA is a potent exonic splicing enhancer , 2008, Nucleic acids research.

[17]  Jie Zhong,et al.  G-quadruplexes regulate Epstein-Barr virus-encoded nuclear antigen 1 mRNA translation. , 2014, Nature chemical biology.

[18]  J. Beaudoin,et al.  5′-UTR G-quadruplex structures acting as translational repressors , 2010, Nucleic acids research.

[19]  M. Teulade‐Fichou,et al.  Development of a high-throughput G4-FID assay for screening and evaluation of small molecules binding quadruplex nucleic acid structures , 2011, Analytical and bioanalytical chemistry.

[20]  E. Kieff,et al.  Nucleolin is important for Epstein–Barr virus nuclear antigen 1-mediated episome binding, maintenance, and transcription , 2013, Proceedings of the National Academy of Sciences.

[21]  R. Fåhraeus,et al.  The long‐lasting love affair between the budding yeast Saccharomyces cerevisiae and the Epstein‐Barr virus , 2015, Biotechnology journal.

[22]  Daekyu Sun,et al.  Identification and Characterization of Nucleolin as a c-myc G-quadruplex-binding Protein* , 2009, The Journal of Biological Chemistry.

[23]  R. Fåhraeus,et al.  A yeast-based assay identifies drugs that interfere with immune evasion of the Epstein-Barr virus , 2014, Disease Models & Mechanisms.

[24]  R. Fåhraeus,et al.  Epstein Barr Virus-Encoded EBNA1 Interference with MHC Class I Antigen Presentation Reveals a Close Correlation between mRNA Translation Initiation and Antigen Presentation , 2010, PLoS pathogens.

[25]  Giorgio Palù,et al.  Nucleolin stabilizes G-quadruplex structures folded by the LTR promoter and silences HIV-1 viral transcription , 2015, Nucleic acids research.

[26]  N. Maizels,et al.  High Affinity Interactions of Nucleolin with G-G-paired rDNA* , 1999, The Journal of Biological Chemistry.

[27]  R. Rodriguez,et al.  G-quadruplex interacting small molecules and drugs: from bench toward bedside , 2014, Expert review of clinical pharmacology.

[28]  D. Thorley-Lawson,et al.  The curious case of the tumour virus: 50 years of Burkitt's lymphoma , 2008, Nature Reviews Microbiology.

[29]  P. Philippsen,et al.  Additional modules for versatile and economical PCR‐based gene deletion and modification in Saccharomyces cerevisiae , 1998, Yeast.

[30]  D. Bearss,et al.  Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[31]  L. Sokol,et al.  EBV-Related Malignancies, Outcomes and Novel Prevention Strategies. , 2016, Infectious disorders drug targets.

[32]  P. Hainaut,et al.  G-quadruplex structures in TP53 intron 3: role in alternative splicing and in production of p53 mRNA isoforms. , 2011, Carcinogenesis.

[33]  Matthias Peter,et al.  Degradation of Hof1 by SCFGrr1 is important for actomyosin contraction during cytokinesis in yeast , 2005, The EMBO journal.

[34]  Mihee M. Kim,et al.  Enhanced translation by Nucleolin via G-rich elements in coding and non-coding regions of target mRNAs , 2011, Nucleic acids research.

[35]  M. Teulade‐Fichou,et al.  A Hitchhiker′s Guide to G‐Quadruplex Ligands , 2008 .

[36]  John J Miles,et al.  Endogenous Presentation of CD8+ T Cell Epitopes from Epstein-Barr Virus–encoded Nuclear Antigen 1 , 2004, The Journal of experimental medicine.

[37]  K. Murata,et al.  Transformation of intact yeast cells treated with alkali cations. , 1984, Journal of bacteriology.

[38]  R. Fåhraeus,et al.  Self-Inhibition of Synthesis and Antigen Presentation by Epstein-Barr Virus-Encoded EBNA1 , 2003, Science.

[39]  L. Young,et al.  Epstein–Barr virus: 40 years on , 2004, Nature Reviews Cancer.

[40]  Scott Frees,et al.  QGRS-Conserve: a computational method for discovering evolutionarily conserved G-quadruplex motifs , 2014, Human Genomics.